Compliance with RSV prophylaxis: Global physicians’ perspectives
Kari S Anderson, Victoria M Mullally, Linda M Fredrick, Andrew L CampbellAbbott Laboratories, Abbott Park, IL, USAAbstract: Respiratory syncytial virus (RSV) is a significant cause of morbidity in high-risk infants. Palivizumab is proven to prevent serious RSV disease, but compliance with prophylaxi...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-07-01
|
| Series: | Patient Preference and Adherence |
| Online Access: | http://www.dovepress.com/compliance-with-rsv-prophylaxis-global-physiciansrsquo-perspectives-a3350 |